A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Alterations in the DNA methylation pattern are a hallmark of leukemias and lymphomas. However, most epigenetic studies in hematologic neoplasms (HNs) have focused either on the analysis of few candidate genes or many genes and few HN entities, and comprehensive studies are required. METHODOLOGY/PRINCIPAL FINDINGS: Here, we report for the first time a microarray-based DNA methylation study of 767 genes in 367 HNs diagnosed with 16 of the most representative B-cell (n = 203), T-cell (n = 30), and myeloid (n = 134) neoplasias, as well as 37 samples from different cell types of the hematopoietic system. Using appropriate controls of B-, T-, or myeloid cellular origin, we identified a total of 220 genes hypermethylated in at least one HN entity. In general, promoter hypermethylation was more frequent in lymphoid malignancies than in myeloid malignancies, being germinal center mature B-cell lymphomas as well as B and T precursor lymphoid neoplasias those entities with highest frequency of gene-associated DNA hypermethylation. We also observed a significant correlation between the number of hypermethylated and hypomethylated genes in several mature B-cell neoplasias, but not in precursor B- and T-cell leukemias. Most of the genes becoming hypermethylated contained promoters with high CpG content, and a significant fraction of them are targets of the polycomb repressor complex. Interestingly, T-cell prolymphocytic leukemias show low levels of DNA hypermethylation and a comparatively large number of hypomethylated genes, many of them showing an increased gene expression. CONCLUSIONS/SIGNIFICANCE: We have characterized the DNA methylation profile of a wide range of different HNs entities. As well as identifying genes showing aberrant DNA methylation in certain HN subtypes, we also detected six genes--DBC1, DIO3, FZD9, HS3ST2, MOS, and MYOD1--that were significantly hypermethylated in B-cell, T-cell, and myeloid malignancies. These might therefore play an important role in the development of different HNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6 Most genes showing hypomethylation of promoter regions in T-PLL are associated with increased gene expression. (A) Genes hypomethylated in T-PLL as compared with CD3+ normal T cells. Genes are arranged alphabetically. (B) Gene expression of hypomethylated genes in T-PLL cases as compared to CD3+ normal T cells. Genes are arranged according to their differential expression in T-PLL vs. normal controls (most upregulated genes on the top). Genes showing at least a 0.5 fold increase (in log2 scale), no expression changes or a 0.5 fold decrease are marked with orange, grey or green lines, respectively, on the right of the heatmap. The CpG content of the promoter sequences of the genes presented is depicted as color code in a separate column (low CpG content (LCP) = blue, intermediate CpG content (ICP) = yellow, high CpG content (HCP) = red, white = data not available). Two of the T-PLL cases (case 1 and case 3) have been studied both by DNA methylation and gene expression profiling. The normal CD3+ T cells used for DNA methylation and gene expression profiling were different. * Gene expression data have been published before by Dürig et al. [26]](https://figures.cochat.ai/paper-figures/1846212f28874940b71f2050bb157d23/a-comprehensive-microarray-based-dna-methylation-study-of-367-hematological-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CpG sites that become more methylated with normal myeloid maturation were not significantly more methylated in independent dataset MDS/myeloproliferative disease (MDS/MPD) (n=13) or AML bone marrow (n=116) (figure S2).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [31]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“All 6 CpG sites that were >20% less methylated in AML cells than NCD34 were from the category of 157 CpG sites that become less methylated with normal myeloid maturation (figure S3).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [31]
Experimental — accuracy not yet measuredIn the citing paper
“In unbiased hierarchical cluster analysis of methylation data from an independent study (31), clusters generated using maturation-responsive CpG discriminated best between NCD34 and NBM, despite 7 to 8-fold more CpG sites in the ‘no methylation change’ category (figure S1).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [31]
In the citing paper
“Methylation of maturation-responsive CpG (hypo and hypermethylated in NCD34) changed in the expected directions from independent NCD34 to NBM (figure S2, red and blue box plots).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [31]
In the citing paper
“Therefore, maturation-responsive CpG sites were over-represented amongst the most hypermethylated CpG sites in AML bone marrow (p<0.0001, Chi-Square test).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [31]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
Román-Gómez, J., Cordeu, L., Agirre, X., Jiménez-Velasco, A., San José-Eneriz, E., Garate, L., Calasanz, M. J., Heiniger, A., Torres, A., & Prosper, F. (2007) · Blood · doi:10.1182/blood-2006-09-047043 · Cited by 168
Self-citationRetractedWHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515 · cited 1×
“Epigenetic changes, which represent reversible modifications that affect gene expression without altering the DNA sequence itself, are also a hallmark of cancer [4,5].”
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663 · cited 1×
“For instance, results from a phase III study have indicated that treatment of patients with higher risk MDS with 5-azacitidine results in significant improvement in overall survival [65].”
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268
Weber, M., Hellmann, I., Stadler, M. B., Ramos, L., Pääbo, S., Rebhan, M., & Schübeler, D. (2007) · Nature Genetics · doi:10.1038/ng1990 · Cited by 2,221
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Bernstein, B. E., Meissner, A., & Lander, E. S. (2007) · Cell · doi:10.1016/j.cell.2007.01.033 · Cited by 2,086 · cited 1×
“The best studied epigenetic change is the hypermethylation of tumor suppressor genes which is reported to be associated with gene inactivation [6].”
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Cited by
Volkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420
“DNA damage/oxidative stress ALDH3B1 encodes an aldehyde dehydrogenase that can protect cells from lipid peroxidation-induced cytotoxicity (Marchitti et al , 2007).”
Heparan sulfate 3-O-sulfation: A rare modification in search of a function
Thacker, B. E., Xu, D., Lawrence, R., & Esko, J. D. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.12.001 · Cited by 234
TET1 is a tumor suppressor of hematopoietic malignancy
Cimmino, L., Dawlaty, M. M., Ndiaye-Lobry, D., Yap, Y. S., Bakogianni, S., Yu, Y., Bhattacharyya, S., Shaknovich, R., Geng, H., Lobry, C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3148 · Cited by 229
Epigenetics: molecular mechanisms and implications for disease
Handel, A. E., Ebers, G. C., & Ramagopalan, S. V. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.11.003 · Cited by 222
Wermann, H., Stoop, H., Gillis, A. J., Honecker, F., van Gurp, R. J., Ammerpohl, O., Richter, J., Oosterhuis, J. W., Bokemeyer, C., & Looijenga, L. H. (2010) · The Journal of Pathology · doi:10.1002/path.2725 · Cited by 182
Self-citationEberle, F. C., Rodriguez‐Canales, J., Wei, L., Hanson, J. C., Killian, J. K., Sun, H., Adams, L. G., Hewitt, S. M., Wilson, W. H., Pittaluga, S., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.033167 · Cited by 146
Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis
Kalari, S., & Pfeifer, G. P. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60010-1 · Cited by 144
Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis
Laffaire, J., Everhard, S., Idbaïh, A., Crinière, E., Marie, Y., de Reyniès, A., Schiappa, R., Mokhtari, K., Hoang‐Xuan, K., Sanson, M., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq110 · Cited by 133
Tong, W.-G., Wierda, W. G., Lin, E. H., Kuang, S.-Q., Bekele, B. N., Estrov, Z. E., Wei, Y., Yang, H., Keating, M. J., & Garcia‐Manero, G. (2010) · Epigenetics · doi:10.4161/epi.5.6.12179 · Cited by 139
The epigenetic landscape of oral squamous cell carcinoma
Jithesh, P. V., Risk, J. M., Schache, A. G., Dhanda, J., Lane, B. S., Liloglou, T., & Shaw, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.568 · Cited by 108
A Genome-Wide Methylation Study of Severe Vitamin D Deficiency in African American Adolescents
Zhu, H., Wang, X., Shi, H., Su, S., Harshfield, G. A., Gutin, B., Snieder, H., & Dong, Y. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.10.059 · Cited by 104
Ang, P. W., Loh, M. C. S., Liem, N. L. M., Lim, P. L., Grieu, F., Vaithilingam, A., Platell, C. F. E., Yong, W. P., Iacopetta, B. J., & Soong, R. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-227 · Cited by 101
Global DNA hypomethylation in cancer: review of validated methods and clinical significance
Toraño, E. G., Petrus-Reurer, S., Fernández, A. F., & Fraga, M. F. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0902 · Cited by 112
Pei, L., Choi, J.-H., Liu, J., Lee, E.-J., McCarthy, B. A., Wilson, J. M., Speir, E. J., Awan, F. T., Tae, H., Arthur, G., et al. (2012) · Epigenetics · doi:10.4161/epi.20237 · Cited by 104
Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma
Ammerpohl, O., Pratschke, J., Schafmayer, C., Haake, A., Faber, W., von Kampen, O., Brosch, M., Sipos, B., Schönfels, W. V., Balschun, K., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26136 · Cited by 116
Self-citationLeonard, S. M., Wei, W., Anderton, J. A., Vockerodt, M., Rowe, M., Murray, P. G., & Woodman, C. B. J. (2011) · Journal of Virology · doi:10.1128/jvi.00468-11 · Cited by 95
Leonard, S. M., Wei, W., Collins, S. I., Pereira, M. S., Diyaf, A., Constandinou-Williams, C., Young, L. S., Roberts, S., & Woodman, C. B. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs157 · Cited by 112
Cayrol, F., Flaqué, M. C. D., Fernando, T. M., Yang, S. N., Sterle, H., Bolontrade, M. F., Amorós, M., Issé, B. A., Farías, R. N., Ahn, H., et al. (2014) · Blood · doi:10.1182/blood-2014-07-587337 · Cited by 100
The Impact of DNA Methylation in Hematopoietic Malignancies
Guillamot, M., Cimmino, L., & Aifantis, I. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.12.006 · Cited by 91
Negrotto, S., Ng, K. P., Jankowska, A. M., Bodo, J., Gopalan, B., Guinta, K., Mulloy, J. C., Hsi, E., Maciejewski, J., & Saunthararajah, Y. (2012) · Leukemia · doi:10.1038/leu.2011.207 · Cited by 90
Álvarez, S., Suela, J., Valencia, A., Fernández, A. F., Wunderlich, M., Agirre, X., Prósper, F., Martín-Subero, J. I., Maiqués-Díaz, A., Acquadro, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012197 · Cited by 91
Self-citationBorssén, M., Palmqvist, L., Karrman, K., Abrahamsson, J., Behrendtz, M., Heldrup, J., Forestier, E., Roos, G., & Degerman, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065373 · Cited by 88
Hassler, M. R., Pulverer, W., Lakshminarasimhan, R., Redl, E., Hacker, J., Garland, G. D., Merkel, O., Schiefer, A., Simonitsch‐Klupp, I., Kenner, L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.018 · Cited by 82
DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia
Nordlund, J., Bäcklin, C. L., Zachariadis, V., Cavelier, L. B., Dahlberg, J., Öfverholm, I. I., Barbany, G., Nordgren, A., Övernäs, E., Abrahamsson, J., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-014-0039-z · Cited by 84
Epigenetic regulation of miRNA genes in acute leukemia
Agirre, X., Martinez-Climent, J. A., Odero, M. D., & Prósper, F. (2011) · Leukemia · doi:10.1038/leu.2011.344 · Cited by 82
Self-citationPolycomb proteins in hematologic malignancies
Martin-Perez, D., Piris, M. A., & Sanchez-Beato, M. (2010) · Blood · doi:10.1182/blood-2010-05-267096 · Cited by 65
Schmidt, J., Salaverría, I., Haake, A., Bonzheim, I., Adam, P., Montes‐Moreno, S., Piris, M. A., Fend, F., Siebert, R., & Quintanilla‐Martínez, L. (2013) · Leukemia · doi:10.1038/leu.2013.307 · Cited by 69
Self-citationVilas‐Zornoza, A., Agirre, X., Martín‐Palanco, V., Martín-Subero, J. I., José‐Eneriz, E. S., Gárate, L., Álvarez, S., Miranda, E., Rodríguez‐Otero, P., Rifón, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017012 · Cited by 58
Self-citationHwang, J.-A., Kim, Y., Hong, S.-H., Lee, J., Cho, Y. G., Han, J., Kim, Y.-H., Han, J., Shim, Y. M., Lee, Y.-S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079634 · Cited by 63
Pérez, C., Pascual, M., Martín-Subero, J. I., Bellosillo, B., Segura, V., Delabesse, É., Álvarez, S., Larráyoz, M. J., Rifón, J., Cigudosa, J. C., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.084160 · Cited by 59
Self-citationProfiling Epigenetic Alterations in Disease
Martín-Subero, J. I., & Esteller, M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8216-2_12 · Cited by 55
Lauss, M., Aine, M., Sjödahl, G., Veerla, S., Patschan, O., Guðjónsson, S., Chebil, G., Lövgren, K., Fernö, M., Månsson, W., et al. (2012) · Epigenetics · doi:10.4161/epi.20837 · Cited by 53
The Emerging Roles of Heparan Sulfate 3-O-Sulfotransferases in Cancer
Denys, A., & Allain, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00507 · Cited by 54
Zhang, J., Xu, D., Hao, K., Zhang, Y., Chen, W., Liu, J., Gao, R., Wu, C., & Marinis, Y. Z. D. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa189 · Cited by 58
Hill, V. K., Dunwell, T. L., Catchpoole, D. R., Krex, D., Brini, A. T., Griffiths, M., Craddock, C., Maher, E. R., & Latif, F. (2011) · Epigenetics · doi:10.4161/epi.6.3.14404 · Cited by 54
Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer
Molina‐Pinelo, S., Salinas, A. M., Moreno‐Mata, N., Ferrer, I., Suárez, R., Andrés‐León, E., Rodríguez‐Paredes, M., Gutekunst, J., Lewintre, E. J., Camps, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10611 · Cited by 49
A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia
Wong, N. C., Ashley, D. M., Chatterton, Z., Parkinson-Bates, M., Ng, H. K., Halemba, M. S., Kowalczyk, A., Bedő, J., Wang, Q., Bell, K. M., et al. (2012) · Epigenetics · doi:10.4161/epi.20193 · Cited by 42
Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications
Vegliante, M. C., Royo, C., Palomero, J., Salaverría, I., Bálint, B., Martín‐Guerrero, I., Agirre, X., Lujambio, A., Richter, J., Xargay‐Torrent, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021382 · Cited by 42
Self-citationEckmann-Scholz, C., Bens, S., Kolarova, J., Schneppenheim, S., Caliebe, A., Heidemann, S., von Kaisenberg, C., Kautza, M., Jonat, W., Siebert, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039014 · Cited by 42
Self-citationEpigenetic Alterations in Epstein-Barr Virus-Associated Diseases
Niller, H. H., Bánáti, F., Salamon, D., & Minárovits, J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24738-0_3 · Cited by 41
Mayol, G., Martín-Subero, J. I., Ríos, J., Queirós, A. C., Kulis, M., Suñol, M., Esteller, M., Gómez‐González, S., García, I., de Torres, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048401 · Cited by 43
Choi, J.-H., Li, Y., Guo, J., Pei, L., Rauch, T. A., Kramer, R. S., Macmil, S. L., Wiley, G. B., Bennett, L. B., Schnabel, J. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013020 · Cited by 42
Rey, M. D., O’Hagan, K., Dellett, M., Aibar, S., Colyer, H. A. A., Alonso, M. E., Díez‐Campelo, M., Armstrong, R. N., Sharpe, D., Gutierrez, N. C., et al. (2012) · Leukemia · doi:10.1038/leu.2012.253 · Cited by 41
Hernández‐Vargas, H., Gruffat, H., Cros, M., Diederichs, A., Sirand, C., Vargas-Ayala, R. C., Jay, A., Durand, G., Calvez‐Kelm, F. L., Herceg, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05713-2 · Cited by 37
Pathology, pathogenesis and molecular genetics of follicular NHL
Leich, E., Ott, G., & Rosenwald, A. (2011) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2011.02.003 · Cited by 42
Doo, N. W., Makalic, E., Joo, J. E., Vajdic, C. M., Schmidt, D. F., Wong, E. M., Jung, C., Severi, G., Park, D. J., Chung, J., et al. (2015) · Epigenomics · doi:10.2217/epi.15.97 · Cited by 38
Charalambous, M., & Hernández, A. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.015 · Cited by 38
Eberle, F. C., Hanson, J. C., Killian, J. K., Wei, L., Ylaya, K., Hewitt, S. M., Jaffe, E. S., Emmert‐Buck, M. R., & Rodriguez‐Canales, J. (2010) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090200 · Cited by 36
Rio‐Machín, A., Ferreira, B. I., Henry, T. J., Goméz-López, G., Agirre, X., Álvarez, S., Rodríguez, S., Prósper, F., Calasanz, M. J., Martínez‐López, J., et al. (2012) · Leukemia · doi:10.1038/leu.2012.302 · Cited by 40
Self-citationEpigenetic Heterogeneity of B-Cell Lymphoma: DNA Methylation, Gene Expression and Chromatin States
Hopp, L., Loeffler‐Wirth, H., & Binder, H. (2015) · Genes · doi:10.3390/genes6030812 · Cited by 32
DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist
Benetatos, L., Vartholomatos, G., & Hatzimichael, E. C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1698-9 · Cited by 36
Role of Epigenetics in EBV Regulation and Pathogenesis
Niller, H. H., Tarnai, Z., Decsi, G., Zsedényi, Á., Bánáti, F., & Minárovits, J. (2014) · Future Microbiology · doi:10.2217/fmb.14.41 · Cited by 33
Epstein–Barr virus–host cell interactions: an epigenetic dialog?
Niller, H. H., Szenthe, K., & Minárovits, J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00367 · Cited by 35
Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma
Yoo, K. H., Park, Y.-K., Kim, H.-S., Jung, W., & Chang, S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02578.x · Cited by 31
Jeyapalan, J. N., Noor, D. A. M., Lee, S. H., Tan, C. L., Appleby, V. J., Kilday, J., Palmer, R. D., Schwalbe, E. C., Clifford, S. C., Walker, D. A., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.218 · Cited by 33
Borssén, M., Cullman, I., Norén‐Nyström, U., Sundström, C., Porwit‐MacDonald, A., Forestier, E., & Roos, G. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.08.014 · Cited by 31
Barrio, S., Gallardo, M., Albízua, E., Ubieto, A. J., Rapado, I., Ayala, R. M., Gilsanz, F., Martín-Subero, J. I., & Martínez‐López, J. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200175 · Cited by 25
Imanishi, S., Umezu, T., Ohtsuki, K., Kobayashi, C., Ohyashiki, K., & Ohyashiki, J. H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.008 · Cited by 27
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
Sanford, T. H., Meng, M. V., Railkar, R. S., Agarwal, P. K., & Porten, S. P. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0451-x · Cited by 24
Ohgami, R. S., Ma, L., Ren, L., Weinberg, O. K., Seetharam, M., Gotlib, J. R., & Arber, D. A. (2012) · British Journal of Haematology · doi:10.1111/bjh.12029 · Cited by 25
The promises of personalized medicine
Cascorbi, I. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0858-6 · Cited by 23
Epigenetic Regulation Of Wnt Signaling In Chronic Lymphocytic Leukemia
Bennett, L. B., Taylor, K. H., Arthur, G. L., Rahmatpanah, F. B., Hooshmand, S., & Caldwell, C. W. (2010) · Epigenomics · doi:10.2217/epi.09.43 · Cited by 24
Dreyling, M. H., Hoster, E., Beà, S., Hartmann, E., Horn, H., Hutter, G., Salaverría, I., Pott, C., Trněný, M., Gouill, S. L., et al. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.496507 · Cited by 22
Self-citationFiedler, D., Hirsch, D. D., Hajj, N. E., Yang, H. H., Hu, Y., Sticht, C., Nanda, I., Belle, S., Rueschoff, J., Lee, M. P., et al. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22787 · Cited by 22
DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous Neoplasia
Hernandez, J. M., Siegel, E. M., Riggs, B. M., Eschrich, S. A., Elahi, A. H., Qu, X., Ajidahun, A. O., Berglund, A., Coppola, D., Grady, W. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050533 · Cited by 23
Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
Zhang, M. Y., Călin, G. A., Yuen, K., Jin, D., & Chim, C. S. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00926-1 · Cited by 21
Raynal, N. J. ‐., Momparler, L. F., Rivard, G., & Momparler, R. L. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.04.014 · Cited by 21
Ponciano-Gómez, A., Martínez‐Tovar, A., Vela‐Ojeda, J., Olarte-Carrillo, I., Centeno-Cruz, F., & Garrido, E. (2017) · Tumor Biology · doi:10.1177/1010428317732181 · Cited by 22
Current concepts and challenges to unravel the role of iodothyronine deiodinases in human neoplasias
Goemann, I. M., Marczyk, V. R., Romitti, M., Wajner, S. M., & Maia, A. L. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0097 · Cited by 23
Gulberti, S., Mao, X., Bui, C., & Fournel‐Gigleux, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.009 · Cited by 24
Cancer: evolutionary, genetic and epigenetic aspects
Lichtenstein, A. V. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0010-6 · Cited by 21
Degerman, S., Landfors, M., Siwicki, J. K., Revie, J., Borssén, M., Evelönn, E., Forestier, E., Chrzańowska, K., Rydén, P., Keith, W. N., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.07.001 · Cited by 18
The peripheral whole-blood transcriptome of acute pyelonephritis in human pregnancya
Madan, I., Than, N. G., Romero, R. J., Chaemsaithong, P., Miranda, J., Tarca, A. L., Bhatti, G., Drăghici, S., Yeo, L., Mazor, M., et al. (2013) · Journal of Perinatal Medicine · doi:10.1515/jpm-2013-0085 · Cited by 19
Marwitz, S., Kolarova, J., Reck, M., Reinmuth, N., Kügler, C., Schädlich, I., Haake, A., Zabel, P., Vollmer, E., Siebert, R., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.79 · Cited by 17
Self-citationPrecision Medicine in Lymphoma by Innovative Instrumental Platforms
Paolo, A. D., Arrigoni, E., Luci, G., Cucchiara, F., Danesi, R., & Galimberti, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01417 · Cited by 18
Enjuanes, A., Alberó, R., Clot, G., Navarro, A., Beà, S., Pinyol, M., Martín-Subero, J. I., Klapper, W., Staudt, L. M., Jaffe, E. S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28321 · Cited by 21
Self-citationDNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer
Goldmann, T., Schmitt, B., Müller, J., Kröger, M., Scheufele, S., Marwitz, S., Nitschkowski, D., Schneider, M. A., Meister, M. A., Muley, T., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01024-6 · Cited by 16
Self-citationHopp, L., Willscher, E., Loeffler‐Wirth, H., & Binder, H. (2015) · Journal of cancer research updates · doi:10.6000/1929-2279.2015.04.04.1 · Cited by 14
DNA methylation profiling of hepatosplenic T-cell lymphoma
Bergmann, A. K., Fataccioli, V., Castellano, G., Martin‐Garcia, N., Pelletier, L., Ammerpohl, O., Bergmann, J., Bhat, J., Pau, E. C. D. S., Martín-Subero, J. I., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.196196 · Cited by 16
Self-citationRobaina, M. C., Faccion, R. S., Arruda, V. O., de Rezende, L. M. M., Vasconcelos, G. M., Apa, A. G., Bacchi, C. E., & Klumb, C. E. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.023 · Cited by 22
Halldórsdóttir, A. M., Kanduri, M., Marincevic, M., Mansouri, L., Isaksson, A., Göransson, H., Axelsson, T., Agarwal, P., Jernberg‐Wiklund, H., Σταματόπουλος, Κ., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23115 · Cited by 17
Goemann, I. M., Marczyk, V. R., Recamonde‐Mendoza, M., Wajner, S. M., Graudenz, M. S., & Maia, A. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-70892-4 · Cited by 19
Kannenberg, K., Urban, C., & Binder, G. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01844.x · Cited by 14
Bens, S., Ammerpohl, O., Martín-Subero, J. I., Appari, M., Richter, J., Hiort, O., Werner, R., Riepe, F. G., Siebert, R., & Holterhus, P. (2011) · Sexual Development · doi:10.1159/000323807 · Cited by 14
Self-citationWeeks, R. J., Ludgate, J. L., Mée, G. L., & Morison, I. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151341 · Cited by 13
Pyrosequencing of DNA Extracted from Formalin-Fixed Paraffin-Embedded Tissue
Doyle, B. J., Ó’Riain, C., & Appleton, K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-055-3_12 · Cited by 11
Tekcham, D. S., & Tiwari, P. K. (2016) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12507 · Cited by 11
Methylation patterns in marginal zone lymphoma
Arribas, A. J., & Bertoni, F. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.09.003 · Cited by 11
Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma
Yoo, K. H., Won, K. Y., Lim, S., Park, Y.-K., & Chang, S. (2014) · Oncology Letters · doi:10.3892/ol.2014.2482 · Cited by 10
Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma
Pellissery, S., Richter, J., Haake, A., Montesinos‐Rongen, M., Deckert, M., & Siebert, R. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.510897 · Cited by 9
Self-citationCurrent Trends and Alternative Scenarios in EBV Research
Minárovits, J., & Niller, H. H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6655-4_1 · Cited by 9
Zhang, M., Călin, G. A., Deng, M., Au-Yeung, R. K. H., Wang, L.-Q., & Chim, C. S. (2022) · Genes · doi:10.3390/genes13010128 · Cited by 9
Molecular signatures in the diagnosis and management of follicular lymphoma
Wrench, D., Montoto, S., & Fitzgibbon, J. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328338ccab · Cited by 10
Hans-Helmut, N., Ferenc, B., & Minárovits, J. (2014) · Journal of Nasopharyngeal Carcinoma · doi:10.15383/jnpc.9 · Cited by 8
Reciprocal Interconnection of miRNome-Epigenome in Cancer Pathogenesis and Its Therapeutic Potential
Ghaffari, S. H., & Bashash, D. (2015) · Springer eBooks · doi:10.1007/978-94-017-9639-2_4 · Cited by 8
Safe and effective medicines for all: is personalized medicine the answer?
Cascorbi, I. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.36 · Cited by 7
Kiani-Zadeh, M., Rezvany, M. R., Namjoo, S., Barati, M., Mohammadi, M. H., Ghasemi, B., Tabatabaei, T., Ghavamzadeh, A., Zaker, F., & Teimoori‐Toolabi, L. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07615-7 · Cited by 5
Next Generation Sequencing: Advances in Characterizing the Methylome
Taylor, K. H., Shi, H., & Caldwell, C. W. (2010) · Genes · doi:10.3390/genes1020143 · Cited by 5
Beekman, R., Kulis, M., & Martín-Subero, J. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800140-0.00009-1 · Cited by 4
Amin, I. I., Kassim, S. K., Hassanien, A. E., & Hefny, H. A. (2013) · International Computer Engineering Conference · doi:10.1109/icenco.2013.6736473 · Cited by 4
Metadata
- Authors
- Martin-Subero, J. I., Ammerpohl, O., Bibikova, M., Wickham-Garcia, E., Agirre, X., Alvarez, S., Brüggemann, M., Bug, S., Calasanz, M. J., Deckert, M., Dreyling, M., Du, M. Q., Dürig, J., Dyer, M. J. S., Fan, J.-B., Gesk, S., Hansmann, M.-L., Harder, L., Hartmann, S., Klapper, W., Küppers, R., Montesinos-Rongen, M., Nagel, I., Pott, C., Richter, J., Román-Gómez, J., Seifert, M., Stein, H., Suela, J., Trümper, L., Vater, I., Prosper, F., Haferlach, C., Cigudosa, J. C., & Siebert, R.
- Affiliations
- Christian-Albrechts-Universität zu Kiel (DE)
- Illumina (United States) (US)
- Universidad de Navarra (ES)
- University Hospital Cologne (DE)
- Ludwig-Maximilians-Universität München (DE)
- University of Cambridge (GB)
- University of Duisburg-Essen (DE)
- University of Leicester (GB)
- University Hospital Frankfurt (DE)
- Spanish National Cancer Research Centre (ES)
- University of Göttingen (DE)
- Munich Leukemia Laboratory (Germany) (DE)
- Corresponding author
- Siebert, Reiner
- ORCID
- Ammerpohl, Ole
- Agirre, Xabier
- Brüggemann, Monika
- Deckert, Martina
- Dreyling, Martin
- Du, Ming Q.
- Dürig, Jan
- Dyer, Martin J. S.
- Fan, Jian-Bing
- Harder, Lana
- Hartmann, Sylvia
- Klapper, Wolfram
- Küppers, Ralf
- Nagel, Inga
- Pott, Christiane
- Richter, Julia
- Seifert, Marc
- Suela, Javier
- Haferlach, Claudia
- Cigudosa, Juan Cruz
- Siebert, Reiner
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-11
- Volume
- 4
- Issue
- 9
- Pages
- e6986
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2737286
- OpenAlex
- W2145166916
- Cited by
- 134
- References
- 65
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 9 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 11 · 2015: 13 · 2014: 11 · 2013: 10 · 2012: 18
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Deposito Adademico Digital Universidad De Navarra (University of Navarra) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Wilhelm Sander-Stiftung
- Deutsche Krebshilfe (70‐3173‐Tr3)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- DNA methylation, hematologic malignancies, promoter hypermethylation, promoter hypomethylation, B-cell lymphoma, T-cell lymphoma, myeloid neoplasms, T-cell prolymphocytic leukemia, CpG content, DBC1, DIO3, FZD9, HS3ST2, MOS, MyoD, epigenetics
- MeSH terms
- B-Lymphocytes, Humans, Promoter Regions, Genetic, T-Lymphocytes, Cluster Analysis, CpG Islands, DNA Methylation, Hematologic Neoplasms, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.